News

NHS England has announced a new single national list of drugs that the Cancer Drugs Fund will routinely fund throughout the whole of England.

Early results from our Sledgehammer Fund have revealed that our TV and press adverts were remembered by nearly half of UK adults, significantly increasing awareness of our cause and the disease.

The Memorial Sloan-Kettering Cancer Center has released new research published in the British Medical Journal today (17 April 2013) which explores whether measuring PSA levels in men aged 40-55 could predict their risk of dying from prostate cancer later in life.